Job Watch
EMBL: Phenomics Team Leader
Competitive Salary:
EMBL:
Phenomics Team Leader
Location:
Cambridge, Cambridgeshire, England
Categories: Job Watch
Lucidity in Dementia (R21/R33 Clinical Trial Optional)
Funding Opportunity RFA-AG-20-017 from the NIH Guide for Grants and Contracts. This FOA is intended to advance scientific understanding of lucidity in dementia by supporting an initial set of retrospective and/or prospective studies that will lay the groundwork for further research on this topic. Studies supported by this FOA will use the R21/R33 phased innovation mechanism to support initial exploratory/developmental aims during the R21 phase followed by further expanded aims during the R33 phase.
Categories: Job Watch, Literature Watch
Lucidity in Dementia (R21 Clinical Trial Optional)
Funding Opportunity RFA-AG-20-016 from the NIH Guide for Grants and Contracts. This FOA is intended to advance scientific understanding of lucidity in dementia by supporting an initial set of retrospective and/or prospective studies that will lay the groundwork for further research on this topic. Studies supported by this FOA will use the R21 mechanism to support initial exploratory/developmental aims that will serve as the foundation for future studies.
Categories: Job Watch, Literature Watch
Notice of Correction to PAR-19-246 "Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed)"
Notice NOT-DA-19-033 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Illumina: Bioinformatics C++ Developer
Competitive salary + Pension, health insurance, gym membership, bonus and many more benefits:
Illumina:
Be part of highly motivated bioinformatics team working on developing fast and accurate analysis workflows for both rare genetic diseases and oncology
Great Abington, Cambridge
Categories: Job Watch
Notice of Change to Eligibility Requirements to the International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
Notice NOT-TW-19-004 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
Funding Opportunity PAR-19-267 from the NIH Guide for Grants and Contracts. Funding Opportunity PurposeThe purpose of this NIH Mentored Research Scientist Development Award (K01) is to provide salary and research support to investigators who are within ten years of completing their terminal professional degree or residency training. Research and mentorship must be in the field of HIV/AIDS translational studies, using nonhuman primates (NHPs) as pre-clinical models. These awards will provide 3 years of support for intensive research career development under the guidance of an experienced mentorship team, with expertise in both the pre-clinical application of NHP HIV/AIDS models and in translation of the results from such studies to clinical application in humans. The expectation is that through this sustained period of research career development and training, awardees will launch independent research careers and become competitive for new research project grant (e.g., R01) funding. This funding initiative addresses all objectives of the fiscal year (FY) 2019/2020 NIH strategic plan for HIV and HIV-Related Research (https://www.oar.nih.gov/hiv-policy-and-research/strategic-plan), including research directed towards prevention and cure of HIV infection; next-generation therapies; understanding the roles of comorbidities, coinfections and complications; and cross-cutting activities such as research training and building capacity.
Categories: Job Watch, Literature Watch
Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-268 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Research Conference Grant (R13) applications to conduct an annual intensive workshop/conference/meeting that addresses the needs of early stage HIV/AIDS researchers utilizing nonhuman primates (NHPs) as they translate preclinical research from NHPs to human clinical trials. The objectives of the meeting(s) supported by this FOA are to provide these early stage HIV/AIDS researchers with guidance on conducting preclinical research to inform clinical trials on reducing the incidence of HIV/AIDS infection, including vaccine development and testing; developing next-generation HIV therapies, including potential cure therapies; treatment of HIV-associated coinfections, comorbidities and complications; and infection prevention strategies. In addition to guidance on translating results to clinical trials, the conference should target developing skills related to networking, grantsmanship, and goal/milestone-driven projects. Conference topics should also include other considerations such as statistical and host genetics considerations; methods to translate the results of NHP studies to clinical trials in humans; and how to develop new NHP research programs to better reflect clinical observations and findings in human HIV/AIDS patients.
Categories: Job Watch, Literature Watch
Wellcome Sanger Institute: Postdoctoral Fellow - Computational
Wellcome Sanger Institute:
Job Reference
83461
Postdoctoral Fellow - Computational
Salary range £31,897 - £39,240 (dependent on experience) plus excellent benefits
Fixed
Hinxton, Cambridgeshire, England
Categories: Job Watch
HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-041 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from investigators to participate in the HLA and KIR Region Genomics in Immune Mediated Diseases Consortium (HLARGC). This cooperative research group supports projects defining the association between variations in the human leukocyte antigen (HLA), also known as the Major Histocompatibility Complex (MHC), and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, including outcomes following cell, tissue, and organ transplantation.
Categories: Job Watch, Literature Watch
HLA and KIR Region Genomics in Immune-Mediated Diseases (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-044 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from investigators to participate in the HLA and KIR Region Genomics in Immune Mediated Diseases Consortium (HLARGC). This cooperative research group supports projects defining the association between variations in the human leukocyte antigen (HLA), also known as the Major Histocompatibility Complex (MHC), and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, including outcomes following cell, tissue, and organ transplantation.
Categories: Job Watch, Literature Watch
Notice of NICHD Participation in PAR-18-822 "Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)"
Notice NOT-HD-19-010 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
Notice NOT-OD-19-104 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)
Notice NOT-OD-19-100 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Award Budget for RFA-HL-19-024 "Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)"
Notice NOT-HL-19-698 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Key Dates in RFA-RM-19-005 " NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)"
Notice NOT-RM-19-007 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
EMBL: Senior Software Developer - European Genome-phenome Archive
Competitive Salary:
EMBL:
Senior Software Developer - European Genome-phenome Archive
Cambridge, Cambridgeshire, England
Categories: Job Watch
EMBL: Development-Operations Engineer - European Genome-phenome Archive
Competitive Salary:
EMBL:
Development-Operations Engineer - European Genome-phenome Archive
Cambridge, Cambridgeshire, England
Categories: Job Watch
EMBL: Ensembl Compara Project Leader
Competitive Salary:
EMBL:
Ensembl Compara Project Leader
Location:
Cambridge, Cambridgeshire, England
Categories: Job Watch
EMBL: Bioinformatics Developer
Competitive Salary:
EMBL:
Bioinformatics Developer
Location:
Cambridge, Cambridgeshire, England
Categories: Job Watch
Pages
